Kenneth Swart has more than three decades of global experience supporting all aspects of clinical development, including a recent tenure at Parexel, where he led and influenced a 20-year evolution in bioanalytical sciences and translational pharmacology, as well as a developing genomic and individualized medicines arena. As a result of his bioanalytical, pharmacology, and immunology contributions to the field, Dr. Swart has maintained a rich tenure in the departments of bioanalytical and organic chemistry at the University of the Free State (Bloemfontein, South Africa). He has been involved in over 4,000 clinical trials, including clinical and bioanalytical protocol development and reviews, regulatory consultancy, bioanalytical execution for PK and PD and other biomarker assessments, data reduction, QC, and report writing.
Swart holds a PhD in pharmacology and bioanalytical chemistry, a master of medical science in pharmacology, a bachelor of medical science (Hons) in pharmacology, and a bachelor of science in chemistry and physiology, all from the University of the Free State in South Africa. He is a member of the American Society of Mass Spectrometry and served as board member and scientific editor for the Journal of Chromatographia.